2상모집 예정
A Clinical Study of V540A in Healthy Female Participants (V540A-005)
연구 개요
Researchers are looking for new ways to prevent cancers related to human papillomavirus (HPV). HPV is a common virus that can cause an infection. There are many different types of HPV. A standard vaccine to prevent HPV-related cancers is V503. V503 protects against 9 types of HPV. V540A is a study vaccine designed to protect against the same (shared) 9 HPV types plus other (unique) HPV types. Researchers want to learn if V540A: * Is safe and if people tolerate it * Works as well as V503 to cause an immune response (the body's response to protect against infections and illnesses) to the shared HPV types.
- 스폰서
- 리드: 머크(MSD)
- 적응증
- Healthy
- 중재
- V540A-2, V540A-3, GARDASIL®9
- 목표 등록
- 525명
- 시작일
- 2026-07-20
- 완료(예정)
- 2028-04-04
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.